This report is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Respiratory Devices
The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.